Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperamylasemia in inflammatory bowel disease.

S Katz1, S Bank, R E Greenberg

  • 1Department of Medicine, Long Island Jewish Medical Center, New Hyde Park, NY.

Journal of Clinical Gastroenterology
|December 1, 1988
PubMed
Summary

Hyperamylasemia, elevated amylase levels, is found in 8% of patients with Crohn's disease. This finding in inflammatory bowel disease (IBD) typically does not indicate pancreatitis and requires no further investigation without other symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medical infrared thermal imaging of canine appendicular bone neoplasia.

BMC veterinary research·2019
Same author

Is it necessary to perform week three dosimetric analysis in low-dose-rate brachytherapy for prostate cancer when day 0 dosimetry is done? A quality assurance assessment.

Brachytherapy·2014
Same author

Pathogenic tau species drive a psychosis-like phenotype in a mouse model of Alzheimer's disease.

Behavioural brain research·2014
Same author

[Ultrasonographic finding and treatment of a cow with pyelonephrosis].

Schweizer Archiv fur Tierheilkunde·2014
Same author

Malignant peripheral nerve sheath tumour in the nasopharynx of a cow.

Schweizer Archiv fur Tierheilkunde·2013
Same author

Fluorescent epibiotic microbial community on the carapace of a Bahamian ostracod.

Archives of microbiology·2013

Area of Science:

  • Gastroenterology
  • Internal Medicine
  • Clinical Chemistry

Background:

  • Idiopathic inflammatory bowel disease (IBD), encompassing ulcerative colitis and Crohn's disease, affects a significant patient population.
  • Hyperamylasemia, characterized by elevated serum amylase levels, can be a confounding finding in patients with gastrointestinal disorders.
  • The clinical significance and underlying causes of hyperamylasemia in IBD patients remain incompletely understood.

Purpose of the Study:

  • To determine the prevalence of hyperamylasemia in patients diagnosed with idiopathic inflammatory bowel disease (IBD).
  • To investigate the potential causes and clinical significance of hyperamylasemia in this patient cohort.
  • To assess the association between hyperamylasemia and specific inflammatory bowel disease (IBD) characteristics, including disease type, activity, and treatment.

Related Experiment Videos

Main Methods:

  • Serum total amylase, pancreatic isoamylase, and salivary isoamylase activity were measured in 180 IBD patients (83 ulcerative colitis, 97 Crohn's disease).
  • Patients with hyperamylasemia underwent further testing, including isoamylase activity measurement, lipase activity assay, macroamylase testing, pancreatic ultrasound, and upper gastrointestinal barium studies.
  • Data on disease site, activity, duration, and therapy were collected and correlated with hyperamylasemia findings.

Main Results:

  • Hyperamylasemia was identified in 8% of patients with Crohn's disease (8 out of 97), with 4 showing elevated pancreatic isoamylase and 2 elevated lipase activity.
  • All patients with hyperamylasemia exhibited normal pancreatic ultrasonography and no duodenal abnormalities on barium studies; macroamylasemia was absent.
  • No significant relationship was found between hyperamylasemia and IBD disease site, activity, duration, or therapy, and no patient developed clinical pancreatitis.

Conclusions:

  • A notable subset of patients with Crohn's disease presents with hyperamylasemia that is not indicative of overt pancreatitis.
  • In the absence of specific clinical indicators or symptoms suggestive of pancreatitis, hyperamylasemia in IBD patients generally warrants no further diagnostic investigation.
  • These findings highlight the importance of understanding the non-pathological causes of elevated amylase in the context of inflammatory bowel disease (IBD).